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Abstract 
Oleuropein aglycone is an important antioxidant compound produced during oleuropein hydrolysis, 
not yet commercially available. Its production from renewable material by green processes is a 
challenge because it permits waste re-use and low environmental impact. In this work, homemade 
asymmetric capillary ceramic membranes were used to develop biocatalytic membranes, which 
were further used to produce oleuropein aglycone from olive leaves and/or commercial oleuropein. 
Results indicated that the biocatalytic system (containing covalently immobilized β-glucosidase) 
promotes the hydrolysis of oleuropein in both monophase and multiphase processes. Furthermore, 
the multiphase biocatalytic system enables the extraction of the hydrophobic oleuropein aglycone in 
an organic phase, before its rearrangement in water. This was achieved by the production, of an 
unstable water-in-oil emulsion (permeate side), on the basis of membrane emulsification process. 
The intensified biocatalytic/extractor system allowed taking shelter the hydrophobic compound in 
the organic phase with good efficiency (90%), protecting it from rearrangement. 
Keywords: oleuropein aglycone, 3,4-DHPEA-EA,  multiphase membrane reactor, capillary 
ceramic membranes, phytotherapic production, waste valorization, green technology 
 
1. Introduction 
In the last century, the use of natural medicine has expanded and many researchers focused their 
work on active components production/extraction from vegetal material. These components are 
known as plant secondary metabolites [1] and possess impressing antioxidant, antimicrobial, 
antiviral and anti-inflammatory properties [2-4]. Phytochemicals in fruits and vegetables act 
synergistically and additively to provide potential health benefits against chronic diseases by 
inhibiting the harmful effects of free radicals [2, 4-6]. The traditional Mediterranean diet is 
characterized by high consumption of foods of plant origin, relatively low consumption of red meat, 
and high consumption of olive oil. Olive oil has been extensively reported in studies to contain 
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physiologically active polyphenols, with  oleuropein aglycone as one of the most important [7, 8]. 
Olive leaves are also rich in polyphenols, especially in oleuropein, rutin, verbacoside, apigenin-7-
glucoside and luteolin-7-glucoside [9], and as a result they can become a renewable material from 
which important non commercially available phytotherapics can be extracted/produced. The 
concentration of polyphenolic compounds in olive leaves changes (60-90 mg/g dry weight), 
depending on the quality, origin and variety [10] of the plant material.  
Oleuropein is the most abundant polyphenol in olive fruits and leaves, which has been used in 
several medical treatments [9], while its hydrolysis products (particularly the isomer of oleuropein 
aglycone, 3,4 DHPEA-EA) are abundant in olive oil. In olives and olive leaves, this compound is 
hydrolyzed by the action of β-glucosidase, forming oleuropein aglycone and a molecule of glucose 
in the first reaction step. It has been demonstrated that the oleuropein aglycone has various types of 
potential applications, such as an antimicrobial agent in some fairly common diseases of olive trees 
[5] or in pharmaceutical sector as antioxidant [6, 8, 9, 11, 12], as bactericidal and bacteriostatic 
agent [13] as platelet aggregation inhibition component  [14], as anticancer and [15], antiviral 
compound [16, 17].  
More recently, oleuropein aglycone has gained increasing interest because of its beneficial effect on 
neuroprotection [18] in neurodegenerative disease and reduction of acute inflammation 
(carrageenan-induced pleurisy) [19]. The main effect is given by its prominent hydrophobic 
character, which allows it to interact directly with biological membranes [20] and to increase its 
local concentration [16], with important consequences on its beneficial pharmacological effect on 
cells.  
In addition, oleuropein derivatives are involved in the production of compounds with organoleptic 
properties, which can influence bitterness of olive oil [21] and olive-based foods. Therefore, 
oleuropein aglycone, once produced, could play an important role in the production of olive oil and 
olive food derivatives. 
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Despite the reported importance of the oleuropein aglycone, this molecule is still commercially 
unavailable, mainly due to its poor stability in water. Typically, about 24 h [13] after its production, 
oleuropein aglycone is rearranged into water soluble compounds and lost preferred properties 
aforementioned. This is why, instead of being in olive mill wastewater, it is normally  present in 
olive oil, and together with hydroxytyrosol, yield in the high antioxidant properties of olive oil [22]. 
In this scenario, a multiphase system to efficiently sequestrate the molecule before its 
rearrangement in water, after its production, is mandatory. This aim will be achieved in this study 
integrating a biocatalytic membrane reactor with a membrane emulsification process [23, 24]. 
The system allows the hydrolysis of oleuropein in the aqueous phase within the biocatalytic 
membrane. The aqueous phase, containing the products, passes on the other side of the membrane, 
where an organic phase is recirculated. In the permeate side, on the basis of membrane 
emulsification process a water-in-oil emulsion is produced, which permits the extraction of the 
hydrophobic oleuropein aglycone. This will promote the production/extraction of the oleuropein 
aglycone in one step, before its rearrangement in water phase. The subsequent solvent removal will 
permit to obtain a solid oleuropein aglycone to be used for formulated products in different 
applications.  
Furthermore, in the logic to develop a green chemistry approach, both pure oleuropein and olive 
leaves extract (containing oleuropein) will be fed to the biocatalytic system to promote the 
production of oleuropein aglycone from waste and renewable material.  
Polymeric membranes were the most commonly used to develop biocatalytic membrane reactors 
[23]. More particularly, asymmetric capillary polymeric membranes possess a number of special 
advantages, especially a very large membrane surface area per unit volume and consequently a high 
surface area available for enzyme immobilization. Although polymeric membranes have been 
widely used for the development of biocatalytic membrane reactors, their organic nature could be a 
limitation to chemical stability, when such membranes are in contact with organic solvents that are 
commonly used for membrane functionalization, as well as in multiphase membrane reactors. In 
  
5 
 
contrast, inorganic membranes are able to overcome these drawbacks thanks to their outstanding 
chemical, thermal and mechanical robustness. Significant efforts have recently been devoted to the 
preparation of ceramic capillary membranes with the same performance of the polymeric ones [25], 
with to date no applications in a multiphase bioreactor or biocatalytic membrane reported. 
In the present work, home-made ceramic capillary membranes with an asymmetric structure were 
prepared and tested, and for the first time used in a multiphase membrane bioreactor for the 
continuous production of oleuropein aglycone. In addition to proving the feasibility of using such 
membranes for both monophase and multiphase biocatalytic membrane reactors, this study will 
focus on the efficient recovery of oleuropein aglycone in a multiphase reactor, well before its 
rearrangement.  
 
2. Materials and Methods 
2.1 Chemicals 
Aluminium oxide powders: 0.01 µm (gamma–alpha, 99.98% metal basis, surface area 100 m2/g), 
0.05 µm (gamma–alpha, 99.5% metal basis, surface area 32–40 m2/g), 0.3 µm (gamma–alpha, 
99.9% metal basis, surface area 15 m
2
/g), and 1 µm (alpha, 99.9% metal basis, surface area 6–8 
m
2
/g),  were purchased from Alfa Aesar (a Johnson Matthey company, London, UK) and were used 
without any treatment. Polyethersulfone (Radal A300, Ameco Performance, Houston, FL, USA), N-
methyl-2-pyrrolidone (HPLC grade, Rathbone, London, UK) and Arlacel P135 
(Polyethyleneglycol30-dipolyhydroxystearate, Uniqema, Paterson, NJ, USA) were used as binder, 
solvent and additive, respectively. Tap water and de-ionized water were used as the external and 
internal coagulants, respectively, during membrane fabrication. Absolute Ethanol (purchased from 
VWR), (3-Aminopropyl) triethoxysilane 99% (APTES) and Glutaraldehyde solution (both 
purchased from Sigma-Aldrich) were used for the functionalization of the alumina membrane. 
Ninhydrin and Glycine (purchased from Sigma-Aldrich) were used as reagent and standard, 
respectively, for the characterization of functionalized membranes. Sodium dihydrogen phosphate 
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(NaH2PO4) and disodium hydrogen phosphate anhydrous (Na2HPO4) (purchased from Sigma-
Aldrich) were used to prepare phosphate buffer solution at pH 6. β-glucosidase from Almond 
(chromatographically purified lyophilized powder, 10-30 U/mg) was obtained from Sigma–Aldrich. 
Oleuropein was purchased from Extrasynthese (France). Olive leaves extract was kindly provided 
by the “Centro di ricerca per l'olivicoltura e l'industria olearia, Rende Italy (CREA-OLI)”. Before 
its use, it was pre-treated by ultrafiltration through 30 kDa capillary membranes in order to remove 
suspended impurities. Centrifugal concentrators Vivaspin 2 (Sartorius Stedim) were used to 
separate the β-glucosidase from reaction mixture in batch system reactor. Ethyl acetate, octanol, 
cyclohexane, squalene, toluene, dichloromethane (purchased from Sigma-Aldrich) were used as 
solvents for the extraction of the reaction product. Acetonitrile and o-phosphoric acid for HPLC 
mobile phase preparation were purchased from VWR and Sigma–Aldrich, respectively. NaOH and 
NaOCl (purchased from Carlo Erba, Milan, Italy) were used for the preparation of the membrane 
cleaning solutions.  
 
2.2 Analytical methods 
BCA assay kit was used to evaluate protein concentration. HPLC was used to measure oleuropein 
and oleuropein aglycone concentrations by adapting a literature method already reported by Mazzei 
et al. [26]. Briefly, the mobile phase (a mixture of acetonitrile and water (21:79) acidified with o-
phosphoric acid up to pH=3) was pumped into a reverse silica Adsorbosphere XL C18 column, 
250–4.6 mm, 5 µm (Grace). The flow rate and pressure were 1.2 ml/min and 145 (±4) bar, 
respectively. The compounds of interest were detected at 280 nm by sample injection of 5 µl. 
To measure the amount of amino groups grafted on the functionalized membrane, the ninhydrin 
method [4] was used. When ninhydrin reacted with grafted amino groups a purple colored 
compound (Ruhemann's purple) is formed in solution. The absorbance measured at 570 nm of the 
colored solution is proportional to grafted amino groups. The standard used for the calibration curve 
is glycine (correlation coefficient between absorbance and concentration: 4000). 
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2.3 Membrane functionalization and biofuctionalization 
Alumina hollow fibre membranes were prepared by a combined phase inversion and sintering 
technique, which has been used in one of our previous research 27. Briefly, Arlacel P135 (1.3 wt%) 
was first dissolved in NMP, before adding the alumina powders (58.7 wt%) at a ratio of 1:2:7 (0.01 
µm:0.05 µm:1 µm). The formed mixture was rolled/milled with 20 mm milling balls for 48 h, prior 
to  the addition of PESf (6.1 wt%), followed by another ball milling of 48 h. The suspension was 
then degassed thoroughly to remove air bubbles, transferred to a 200 ml stainless steel syringe 
controlled by a high pressure syringe pump, and extruded through a tube-in-orifice spinneret at 7 
ml/min into a water bath, with an air-gap of 15 cm. Meanwhile, deionized water (10 ml/min) as the 
internal coagulant was controlled by a second syringe pump and flowed through the central bore of 
the spinneret. The formed precursor fibres were kept in the water bath for 24-48 h, before being 
straightened, dried, and calcined in static air at 1450-1500 °C for 4 h to yield ceramic hollow fibre 
membranes. The porosity of the prepared membrane is 40-50 %”.The prepared membranes have an 
asymmetric structure with a thin sponge-like layer on the shell side and a finger-like voids layer on 
the lumen side. The membrane surface area used was calculated at 10.9 (±0.7) cm
2
, while the 
membrane void volume, which represents the membrane reactor volume, was 0.18 (±0.03) cm
3
. For 
the membranes functionalization two alumina capillary membranes with internal and external 
diameter of 0.9 mm and 1.8 mm, respectively, were housed in Pyrex module of 100 mm long. A 
peristaltic pump feeds the reagent for functionalization or biofunctionalization and two pressure 
gauges measure inlet and outlet pressures. Figure 1 schematizes the steps employed for membrane 
functionalization and biofunctionalization. 
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Fig. 1. Scheme of ceramic capillary membranes functionalization and biofunctionalization 
 
The membrane was firstly treated with APTES (silanization step) and then with GA, in order to 
create aldehydes groups on membrane surface being able to bind the enzyme The percentage of 
glutaraldehyde (10%), selected among the different percentages tested [27], permitted to 
immobilize an enzyme amount which gives the highest enzyme activity. Covalent binding occurs 
through formation of a Schiff base between aldehydic terminal group of glutaraldehyde and amino 
group of silane. In the last step, the β-glucosidase covalent immobilization was carried out by 
feeding the enzymatic solution (50 mM phosphate buffer pH 6.5) to the membrane, at room 
temperature, along the lumen circuit with an axial velocity of 0.033 m/s and a transmembrane 
pressure of 0.05 bar for 16 h. Membranes were then rinsed with buffers at different pH values (5.5, 
6.5, 8.5) (washing solution) to remove any reversibly adsorbed enzyme.  
The amount of immobilized protein was determined by mass balance according to the following 
equation: 
                                   (1)          
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where m indicates the immobilized protein mass in the membrane, C and V represent the 
concentration and volume, respectively; the subscripts i, f and ws indicate the initial, final, and 
washing solutions, respectively. The protein concentration was measured by BCA kit as reported in 
the section analytical methods. 
The amount of immobilized enzyme as a function of the initial protein concentration was also 
studied, aiming at optimizing the initial protein concentration needed. The initial β-glucosidase 
concentrations used as feed solutions were: 0.05, 0.10, 0.15, 0.20 and 0.40 mg/ml. 
 
2.4 Monophasic and multiphasic biocatalytic membrane reactors  
The hydrolysis reaction was carried out in the monophasic and in multiphasic biocatalytic 
membrane reactors (Fig. 2), feeding the substrate from shell to lumen. Samples were taken from 
retentate and permeate as a function of time to determine the presence/amount of the oleuropein, 
oleuropein aglycon by HPLC, and glucose. This last one was quantified by glucose assay kit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B) 
A) 
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Fig 2. Schematic representation of the monophasic and multiphasic BMR with immobilized β-
glucosidase. PG: pressure gauges, P: peristaltic pump, v: valve A) monophase bioacatalytic 
membrane reactor, B) multiphase biocatalytic membrane reactor 
 
The main difference between the two reactors is that in the multiphase membrane system a selected 
organic phase is continuously flowing along the lumen side of membranes generating a permeate 
stream consisting of a water-in-oil emulsion.   
When the β-glucosidase reaction was carried out in the multiphase system the permeate flow rate of 
the water phase was calculated measuring the water volume in the permeate as a function of time by 
a cylinder. This is possible since the unstable emulsion produced instantaneously separates from the 
organic phase once collected. The feed volume decrease is also measured as a function of time with 
a cylinder.In addition to the catalytic/separation activity in monophase reactor, membranes in the 
multiphase system enable the dispersion of the aqueous phase (containing the products and the 
unreacted substrate) in the organic phase, which is recirculated on the other side of the membrane 
on the basis of a membrane emulsification process.  
In this way the feed containing the substrate passes through the biocatalytic membrane, where the 
reaction occurred, then, the products and the unreacted substrate pass on the other side of the 
membrane, where the unstable water-in oil emulsion was formed. Once collected, the emulsion 
spontaneously separates permitting to recover the different phases, containing the different 
compounds extracted between them, on the basis of their partition coefficient.   
The biocatalytic membrane reactors were fed with solutions containing commercial oleuropein or 
extract from olive leaves containing the same substrate (2.5 mM oleuropein, axial velocity of 4.2
-
m/s, pressure of 0.3 bar). In particular, olive leaves extracts belonging to three different cultivars 
(Ottobratica, Sinopolese, Ciciariello) were analyzed in order to establish which of them contained 
the highest oleuropein amount. The harvesting period of olive leaves used for the extraction is July 
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2014. Before using it as the feed, leaves extract solution was ultrafiltered (30 kDa polysulphone 
membranes) to eliminate impurities and appropriately adjusted in pH (6.5) and oleuropein 
concentration (2.5 mM).  
During the reaction, the biocatalytic membrane module was kept at 25 °C by thermostatic baths. 
The reaction rate in the reactors was derived from the balance equation:  
IN-OUT+PROD= ACC    (2) 
where IN and OUT take into the account the mass of substrate that enters and leave the system, 
PROD and ACC are the production and the accumulation of targeted product in the same system.  
For the mentioned reactors it becomes:  
        
dt
dVC
VvFCFC rOUTIN   (3) 
 
where F is the flow rate (volume/time), C is the substrate concentration (mass/volume); vr is the 
volumetric reaction rate (mass/time volume); V is the reaction volume; t is the time.  
In these systems, the substrate flow (IN and OUT) occurs by convection and the reaction takes 
place within the asymmetric porous membrane level, which represents the reactor volume. At the 
steady state each membrane micropore works as a continuous stirred microreactor, so the overall 
membrane matrix can be assimilated to a continuous stirred tank reactor (CSTR) working at the 
steady state. 
In this system, the term ACC = 0, so the equation number 3 becomes: 
            0 VvFCFC rOUTIN       (4) 
And the reaction rate is calculated as follows: 
       
V
CCF
v
pf
r
)( 
          (5)  
For the stirred tank reactor the flow term is zero and production is equal to accumulation, so the 
reaction rate is calculated as time variant concentration (C) from the linear section of the curve C vs 
t.  
     
dt
dC
vr                     (6)   
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After the reaction, the biocatalytic membranes were completely regenerated, removing the attached 
enzyme, using the following developed method: 2% (v/v) of detergent solution, containing 20 wt. % 
of NaOH, 2.5 wt. % of NaOCl and 77.5 wt. % of water, was pressed through the membrane with a 
transmembrane pressure of 0.4 bar for 1 h. Membranes were then rinsed several times with 
deionized water, before next use. 
 
2.4.1 Selection of organic solvents for multiphase membrane reactor 
A specific requirement of the solvents to be used as extracting agent in the multiphase system is 
high oleuropein aglycone extraction, in order to avoid its rearrangement in water. Then, with the 
aim to select the best organic solvent, the partition coefficient at 25°C of oleuropein aglycone 
between water and organic phase was determined as follows. An aqueous solution of oleuropein 
aglycone with an initial concentration of 20 mg L
-1 
was emulsified with ethyl acetate, by a rotor-
stator homogenizer (10,000 rpm for 1 minute). The concentration of oleuropein aglycone after the 
single extraction, both in the aqueous phase and in organic phase, was measured by HPLC as shown 
in paragraph 2.2. Partition coefficient was calculated by the equilibrium concentration ratio of the 
oleuropein aglycone (A) in the organic ([A]o) and aqueous phases ([A]w) according to the following 
equation 7: 
    
    
    
                                   (7) 
 
 
Furthermore, degree of extraction E was evaluated as follows (equation 8): 
 
   
      
     
                                  (8)     
 
where        are moles of oleuropein aglycone in the aqueous phase and        are the moles in 
the organic phase at equilibrium. 
If VW and VO are the aqueous and organic phase volumes, respectively, then (equation 9): 
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                                        (9) 
 
2.5 Stirred tank reactor  
The free enzyme performance was evaluated in a stirred tank reactor (STR) using the following 
procedure: oleuropein hydrolysis reaction was carried out in 25 ml of total volume, with a reaction 
mixture composed by 23.5 ml of substrate solution and 1.5 ml of β-glucosidase solution (0.13 
mg/ml). The reaction was carried out at 25°C. Both enzymatic and oleuropein solutions were 
prepared by dissolving their respective lyophilized powders in 50 mM phosphate buffer pH 6.5. In 
some experiments, glucose was added in the initial reaction mixture in order to monitor its effect as 
enzyme inhibitor. The initial oleuropein concentrations tested were 0.63, 1.25, and 2.50 mM. For all 
the mentioned initial substrate concentration the reaction was carried out in absence of glucose 
(inhibitor) and when its concentration was 1.25 and 2.50 mM, respectively (Supporting 
information). Samples of reaction mixture were taken as a function of time each 30 seconds. In 
order to stop the reaction, by enzyme denaturation, and to remove the enzyme from the reaction 
mixture, the sample was first kept at 100°C and then filtered through centrifugal concentrators 
Vivaspin 2 (Sartorius). 
 
3. Results and discussion 
3.1 Membrane functionalization and biofunctionalization 
The membrane functionalization and biofunctionalization is a crucial step to guarantee good 
performance in the membrane bioreactor. The amount of the amino groups per unit membrane 
surface generated after the functionalization process was 1.26×10
-3
 (±1.56×10
-4
) mmol/cm
2
. The 
initial water permeability of native membranes decreased by about 37% after the silanization 
process, and by 47% after the treatment with glutaraldehyde (10 %).  
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Besides, prior to enzyme immobilization on functionalized membrane, blank experiments were 
carried out, ultrafiltrating enzyme solution through native membranes, to exclude immobilization 
due to enzyme adsorption or entrapment. Mass balance according to equation 1, as well as the 
completely restored permeability (507 (±20) L/hm
2
bar) demonstrated the absence of enzyme 
adsorption on functionalized membrane.  
Different concentrations of enzyme solution (0.05, 0.1, 0.2, 0.4 mg/ml) were used to 
biofunctionalize the membranes resulting in 0.9, 2.2, 5, and 7.8 mg of immobilized enzyme, 
respectively. These results indicated that the amount of immobilized enzyme increases by 
increasing the concentration of the initial enzyme solution. But, as it can be seen in Fig. 3, the 
increasing of oleuropein conversion is observed until an initial enzyme concentration of 0.2 mg/ml 
is used with a corresponding immobilized enzyme of 5 mg.  
 
 
Fig. 3. Amount of immobilized enzyme and oleuropein conversion as a function of initial 
concentration of enzymatic solution. 
 
Indeed, when the membrane with a higher amount of immobilized enzyme was used, the conversion 
decreased from 36 (±5) % to 22 (±5) %. This was probably due to enzymatic aggregation on the 
membrane surface (crowding phenomenon [28]), which impairs the enzymatic activity, as observed 
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when the same membrane was used to immobilize lipase
 27
, or immobilizing lipase, protein G and 
Albumin on polymeric membranes 
28
. The conversion achieved is in line with literature, where 
polymeric membranes and enzyme physical entrapment was used
26
.
 
Applying the membrane cleaning procedure to remove the enzyme, reported in Materials and 
Methods, the initial water permeability (507(±20) L/hm2bar) was completely restored, also after 6 
different enzyme immobilization cycles. This will permit the re-use of the membrane during 
continuous production process in case of enzyme denaturation.  
 
3.2 Performance of monophasic biocatalytic membrane reactor  
Hydrolysis reaction of oleuropein was performed by using biocatalytic membranes loaded with 
different amounts of enzyme, as above mentioned, and by using pure oleuropein solution (2.5 mM) 
or olive leaves extracts containing oleuropein as the feed. A constant permeate flux is observed 
(1.50 L/hm
2
, operative conditions: 0.3 bar, 0.3 ml/min, 25°C), confirming that substrate does not 
interact with the membrane itself, since it can freely pass through the biocatalytic membrane.   
The olive leaves extract from the cultivar “Ciciariello” was used as feed solution since, in 
comparison with the other cultivars (Sinopolese, Ottobratica), it contains the highest amount of 
oleuropein (2.85 mg/ml). In this extract other polyphenols are present, which do not alter the 
catalytic action of β-glucosidase towards oleuropein, since the enzyme is highly specific for its 
substrate, as previously demonstrated by Conidi et al. [29]. Same constant permeate flux as a 
function of time (1.50 L/hm
2
, operative conditions: 0.3 bar, 0.3 ml/min, 25°C), was also observed 
when ultrafiltered olive leaves extract was fed to the biocatalytic system, demonstrating the little 
interaction between the feed and the membrane.  
2.5 mM of oleuropein solution was fed to the reactor, which passed from shell side to lumen with an 
axial velocity of 4.2×10
-3
 m/s and a permeate flow rate of 0.3 ml/min. Here, the substrate met the 
immobilized biocatalyst and hydrolysis reaction occurred. Aglycone, glucose (reaction products) 
and unreacted oleuropein were recovered in the lumen circuit of the system. Same operation mode 
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and operative conditions were then repeated by changing the feed of the reaction with olive leaves 
extract. Also in this last case, the oleuropein initial concentration was set to 2.5 mM. Any product 
was detected in the feed and in the retentate collected as a function of time, confirming that it is 
produced and removed at each passage through the membrane. 
A constant substrate concentration profile (Fig. 4a) that enters into the biocatalytic system (IN) and 
the one unconverted and recovered into the permeate (OUT) is observed. This demonstrated that the 
system is a continuous system, characterized from time invariant conditions at the steady-state.  
The reaction mixture (reagent and products) is continuously removed from the reaction site and no 
accumulation occurs. So, the reaction rate is calculated by the equation reported in Materials and 
Methods section. 
 
A) 
B) 
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Fig. 4. Oleuropein concentration in a monophasic biocatalytic membrane reactor (a), and 
conversion obtained when the system was fed with pure oleuropein or with leaves extract 
containing oleuropein (b). Enzyme immobilized used: 5 mg. 
A conversion of about 36 (± 4) % was obtained at each passage of oleuropein through the 
biocatalytic membrane (residence time: 0.6 min) with a reaction rate of 8.6×10
-4
 (±1.0×10
-4
) 
mmol/cm
3
min.  
The biocatalytic membrane was re-used for 6 reaction cycles and for a total observation period of 
about 18 hours, demonstrating constant performance as a function of time. 
The same constant conversion was achieved by using olive leaves extract as the feed (Fig. 4b), 
confirming that the enzyme activity is not altered from the presence of other polyphenols and more 
importantly that the leaves extract can be used as source to produce phytotherapic compounds by a 
biocatalytic membrane system. Also by using this feed the reaction was repeated for 6 reaction 
cycles for a total observation period of 18 hours, and also in this case a constant conversion was 
obtained with no decay in system performance.  
In the STR a conversion of about 50 % after 300 minutes was obtained, while the reaction rate is 
1.8
-4
 mmol/cm
3
min (± 1.0
-5
). In in this system enzyme inhibition by the other co-product (glucose) 
is present as demonstrated in supporting information. For this reason, in this reactor there is the 
problem to separate reagents when the maximum conversion was reached, which needs additional 
downstream processes. In this particular case the continuous removal of the product in the BMR is 
an additional advantage. 
A comparison of the obtained results with another continuous biocatalytic membrane reactor 30, in 
which the enzyme was physically immobilized onto polymeric membranes, underlines that the 
covalent immobilization does not alter the enzyme catalytic activity since the enzyme has very 
similar reaction rate (physical entrapment: 6.9
-4
 (±3
-5
) mmol/min·cm
3
; present work: 6.8
-4
 (±4
-5
) 
mmol/min·cm
3
), in the case in which similar enzyme amount was immobilized. But it must be 
pointed out that about the same reaction rate value was obtained with a lower biocatalyst 
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concentration (physical entrapment 7.2
-5 
(±3
-6
) mmol/cm
3
, present work: 5.5
-5
(±2
-6
) mmol/cm
3
), 
indicating a good performance of the enzyme also when covalently immobilized onto a membrane. 
Besides, the covalent immobilization could preserve the catalytic system from the enzyme leaching 
during long-term operation.  
 
3.3.1 Selection of organic solvent for multiphase biocatalytic membrane reactor 
In Table 1 some properties of the different organic solvents tested for oleuropein extraction are 
summarized, together with their extraction capacity towards the compound of interest. 
Results evidenced that oleuropein aglycone extraction occurs only in ethyl acetate and octanol. 
Indeed, about 47% of extraction was obtained in the case of octanol, while about 62% into ethyl 
acetate. An ideal organic solvent should be very slightly soluble in water and should have low 
boiling temperature and low toxicity. The low boiling temperature will promote an easy solvent 
evaporation, after separation from water phase, in permeate samples. 
 
Table 1. Organic solvent properties and related extraction percentage of oleuropein 
aglycone from water 
Organic solvent Solubility in 
water (%) v/v 
Oleuropein aglycone 
extracted (%)* 
Boiling point  
(°C) 
Cyclohexane 0.01 0 81.0 
Octanol 0.03 47 188.0 
Ethyl Acetate 8 62 77.1 
Squalene Not soluble 0 275.0 
Toluene 0.05 0 110.6 
Dichloromethane 1.3 3 39.6 
* 50:50 (v/v) organic/water phase (containing oleuropein aglycone) emulsion  
 
Despite octanol has a lower solubility in water than ethyl acetate, its high boiling point (188°C) 
represents a problem for solvent removal and solid residue recovery. Thus, a lower boiling point, as 
in the case of ethyl acetate is preferred. 
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Besides, ethyl acetate is defined “recommended/preferred” solvent on the basis of green solvent 
choice criteria given by ‘Registration, Evaluation, Authorisation and Restriction of Chemicals’ 
(REACH) and the recommendations of pharmaceutical industry [31]. This will permit its direct use, 
after enriching it of polyphenols instead of other solvents, in food formulation production [32]. On 
the basis of the partition coefficient reported on Fig. 5, the ratio of the ethyl acetate/water to be used 
in the multiphase system to obtain a high extraction of the compound of interest was fixed to 1:5 
(v/v). 
 
Fig. 5. Partition coefficient of oleuropein aglycone in ethyl acetate 
 
The oleuropein hydrolysis in ceramic multiphase biocatalytic membrane reactor was carried out by 
using a ceramic membrane containing 5 mg of covalently immobilized β-glucosidase. The aqueous 
phase containing the oleuropein was recirculated into the shell of the system with an axial velocity 
of 4.2·10
-3
 m/sec. It passed through the biocatalytic membrane at a flow rate of 0.3 ml/min, 
resulting in a residence time of about 0.96 min. On the other side of the membrane the ethyl acetate 
solution was recirculated with an axial velocity of 1.6×10
-3
 m/sec. So the aqueous solution 
containing the products met the organic phase in lumen and forms the unstable water-in-oil 
emulsion. In this case the ratio of water that passes through the membrane and ethyl acetate 
recovered into the permeate was 1/5 (v/v). 
y = 1.596x 
R² = 0.9959 
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
0.0 2.0 4.0 6.0 8.0 10.0 12.0 
O
le
u
ro
p
ei
n
 a
gl
yc
o
n
e 
in
 E
A
 (
m
g/
L)
 
Oleuropein aglycone in water (mg/L) 
  
20 
 
In order to evaluate the efficiency of the multiphasic biocatalytic membrane reactor, prior to 
recirculate the organic phase into the system, the performance of the immobilized β-glucosidase 
was studied under a single-phase condition. Once the steady-state was reached, the ethyl acetate 
was recirculated into the lumen side in order to promote the extraction of the oleuropein aglycone. 
 
 
 
Fig. 6. Concentration profile of oleuropein that enters in the biocatalytic membrane (IN) and 
collected in the permeate phase after hydrolysis (OUT) in monophasic biocatalytic membrane 
reactor and in multiphasic biocatalytic membrane reactor. The black dashed line represents the time 
where it was started the recirculation of the organic phase. 
 
Constant concentration profiles (Fig. 6) of oleuropein that enters into the biocatalytic membrane 
(IN) and the one collected into the aqueous phase in the permeate is obtained, confirming that the 
system works as a continuous system also when the organic phase was recirculated into the lumen 
side. Also in this case at each passage through the membrane a conversion of 36 (±2) % was 
reached. The ethyl acetate collected fractions were separated from the aqueous phase and 
evaporated, then the solid powder was suspended in buffer phase (50 mM phosphate buffer, pH 6.5) 
and the amount of oleuropein aglycone and oleuropein were measured again by HPLC. When the 
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oleuropein conversion was about 36 (±2) %, the extraction of the compound of interest into the 
organic solvent was 90% at each passage through the membrane, in accordance with the oleuropein 
aglycone partition coefficient (Fig.6). This high value of extraction percentage allows preserving 
the hydrophobic compound from a possible rearrangement in water.  
Considering that the prize of polyphenols contained in olive oil, such as oleuropein aglycone, is 
very high (e.g. hydroxytyrosol about 2700 euro per gram, Extrasynthese), the development of a 
method to isolate in one step a non-commercially available compound with 90 % of extraction in a 
pure solvent could be highly advantageous from an economic point of view. 
The further solvent removal permitted to obtain a solid powder enriched of oleuropein aglycone 
which has a major versatility respect to the dissolved forms and it could be used in several 
formulations in many fields. Besides, the solid form promotes higher aglycone stability, since 
powders are generally less reactive in comparison with solutions.  
The evaporation process was used in this system to demonstrate the concept, but less energy 
intensive processes can be applied, such as solvent resistant nanofiltration coupled with membrane 
crystallization.  
 
Conclusions 
A multiphase biocatalytic membrane system was developed and compared with a monophasic 
membrane system for oleuropein aglycone production starting from pure oleuropein or olive leaves 
extract. The multiphase system permitted to produce and simultaneously extract the hydrophobic 
aglycone in a pure solvent. A solid powder enriched of oleuropein aglycone can be obtained by a 
subsequent solvent removal.  
The intensified biocatalytic/extractor reactor proposed well respond to the need to develop “green 
systems”, since it promotes both the valorization of renewable material (olive leaves), and the 
production/stabilization of a high added value phytotherapic compound by a continuous process. 
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Highlights 
- Hydrophobic oleuropein aglycone is an antioxidant not commercially available  
-It can be continuously produced from olive leaves by an intensified membrane process   
-Multiphase biocatalytic membrane reactor allowed produce/extract the aglycone 
-An unstable water-in-oil emulsion produced in the permeate allowed the extraction  
- Enriched powder of oleuropein aglycone can be produced after solvent evaporation 
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